Diabetes Drug Breakthrough: New Research Suggests GLP-1R Agonists Could Slow Parkinson’s Progression
Paris, France – A recent study conducted in Paris, France suggests that a drug similar to those used in “skinny jabs” could potentially slow down the progression of symptoms associated with Parkinson’s disease. Parkinson’s is a neurodegenerative condition that affects over 10 million people globally, resulting in the gradual loss of nerve cells in the brain and leading to movement difficulties, balance issues, and memory problems. While current treatments aim to manage symptoms, there is …